Speech-Language Pathologists in Lodi, CA Accepting Medicare

22 Speech-Language Pathologists found. Showing 1 - 20

Mrs. Tamara Leah Lang, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 S Ham Ln, Lodi, CA 95242 Phone: 209-368-7141

Colleen Adair Selling, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1209 W Tokay St, Ste.8, Lodi, CA 95240 Phone: 209-367-8547

Brandee Lyn Smith, MS CCC SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1547 Lexington Dr, Lodi, CA 95242 Phone: 209-663-7238

Carol Kooyman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 831 So. Lee Ave., Lodi, CA 95240 Phone: 209-747-4304

Ariel Rene Correa, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1812 W Kettleman Ln Ste 2c, Lodi, CA 95242 Phone: 209-470-2981

Mrs. Sara Marie Peterson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1209 W Tokay St, Suite 8, Lodi, CA 95240 Phone: 209-334-0830

Mackenzie Shiba, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1812 W Kettleman Ln, Lodi, CA 95242 Phone: 209-242-4606

Megan Clayton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 W Tokay St, Lodi, CA 95240 Phone: 209-334-0830

Mrs. Jennifer Marie Wallmark, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 8 S Cambridge Dr, Lodi, CA 95242 Phone: 209-327-8788

Mrs. Sharon Elizabeth Palmer, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 W Tokay St, Lodi, CA 95242 Phone: 209-334-0830    Fax: 209-334-0860

Ciera Noele Mertens, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 W Tokay St, Lodi, CA 95240 Phone: 209-334-0830

Mrs. Cecilia Alma Martinez, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 S Ham Ln, Lodi, CA 95242 Phone: 209-368-7141

Speech Therapy Associates A Speech Language Pathology Corporation Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1209 W Tokay St Ste 8, Lodi, CA 95240 Phone: 209-334-0830    Fax: 209-334-0860

Mrs. Michelle Anne Hulstrom, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2826 Cumbria Way, Lodi, CA 95242 Phone: 209-609-5179    Fax: 209-263-7006

Xinchen Chen Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 N Church St, Lodi, CA 95240 Phone: 530-302-7374

Mrs. Cathy White, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 W Tokay St Ste B, Lodi, CA 95240 Phone: 209-334-0830

Communication Blooms Speech Therapy Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1812 W Kettleman Ln Ste 1, Lodi, CA 95242 Phone: 209-242-4606

Laura Brown Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1200 W Tokay St, Lodi, CA 95240 Phone: 209-334-0830

Sara Rouse, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1209 W Tokay St, Ste 8, Lodi, CA 95240 Phone: 209-334-0830

Kristin Bond, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 221 Mokelumne River Dr, Lodi, CA 95240 Phone: 209-484-1409

News Archive

Increasing physical activity over six years associated with decreased heart failure risk

By analyzing reported physical activity levels over time in more than 11,000 American adults, Johns Hopkins Medicine researchers conclude that increasing physical activity to recommended levels over as few as six years in middle age is associated with a significantly decreased risk of heart failure, a condition that affects an estimated 5 million to 6 million Americans.

Australia's Mesoblast receives nod to start first European trial of allogeneic stem cell treatment for heart attacks

Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor™ in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor™ is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction).

Leica Microsystems introduces new augmented reality imaging technologies for surgical microscopes

Leica Microsystems will be revealing a new generation of augmented reality imaging technologies for surgical microscopes, at the American Association of Neurological Surgeons Annual Scientific Meeting 2017, in Los Angeles, USA.

University of Illinois at Chicago awarded $7.2 million to eliminate health disparities

The University of Illinois at Chicago has been awarded a $7.2 million federal grant to establish the UIC Center of Excellence in Eliminating Health Disparities.

Read more Medical News

› Verified 5 days ago

• 1(current)
• 2